Intracranial Hemorrhage Risk of Intensive Statin in Acute Ischemic Stroke With Cerebral Microbleeds

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 344 participants.

Also called NCT05589454

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 344 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05589454
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT05589454. Randomized; no masking; primary purpose prevention. Start 2023-01 (anticipated); primary completion 2026-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intracranial Hemorrhage Risk of Intensive Statin in Acute Ischemic Stroke With Cerebral Microbleeds
Condition
Acute Ischemic Stroke
Condition
Cerebral Microbleeds
Intervention (Drug)
Atorvastatin Calcium tablets 80mg
Intervention (Drug)
Atorvastatin Calcium tablets 20mg
Lead sponsor
Sichuan Provincial People's Hospital (class: other)
Collaborator
Science and Technology Department of Sichuan Province (class: other)

Record details

Record id
cardio:ct-nct05589454
Content hash
757b9b3396806ed51ca3a7b222e15f682c97990decbfee1788a1c714ad794abe